BackAmplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Overview

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Accounts Payable

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's accounts payable is $58M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$58.46M

Peer average

Loading

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Accounts Payable History

Loading

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF vs. peers: Accounts Payable Comparison

Loading

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF (GERM) FAQ

As of the most recent data (June 2026), GERM shows a accounts payable of $58M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GERM's accounts payable is now $58M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF is outperforming or lagging.

Tracking GERM's accounts payable over time shows whether Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF is scaling, shrinking, or reshaping that part of the business. The current reading is $58M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $58M) with ownership activity and broader fundamentals.